{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:37:13Z","timestamp":1782549433886,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI147383"],"award-info":[{"award-number":["AI147383"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cyto.2021.155715","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T07:45:43Z","timestamp":1632728743000},"page":"155715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-7948","authenticated-orcid":false,"given":"Chunsheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Jawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-4004","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha S.","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy J.","family":"McGeachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-2041","authenticated-orcid":false,"given":"Sarah L.","family":"Gaffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155715_b0005","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"Interleukin 17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155715_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cyto.2021.155715_b0015","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.167.8.4137","article-title":"Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production","volume":"167","author":"Starnes","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2021.155715_b0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/cr.2007.35","article-title":"A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses","volume":"17","author":"Chang","year":"2007","journal-title":"Cell Res"},{"issue":"18","key":"10.1016\/j.cyto.2021.155715_b0025","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an Interleukin 17F\/17A Heterodimer in Activated Human CD4+ T Cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.cyto.2021.155715_b0030","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2020.02.004","article-title":"Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling","volume":"52","author":"Goepfert","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cyto.2021.155715_b0040","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.celrep.2017.07.063","article-title":"The IL-17F\/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways","volume":"20","author":"De Luca","year":"2017","journal-title":"Cell Rep"},{"issue":"7796","key":"10.1016\/j.cyto.2021.155715_b0045","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-020-2028-z","article-title":"gammadelta T cells and adipocyte IL-17RC control fat innervation and thermogenesis","volume":"578","author":"Hu","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2021.155715_b0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nature Med"},{"issue":"2","key":"10.1016\/j.cyto.2021.155715_b0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20042279","article-title":"IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together","volume":"201","author":"Bettelli","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-015-0359-0","article-title":"Secukinumab: first global approval","volume":"75","author":"Sanford","year":"2015","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.cyto.2021.155715_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13075-019-1882-2","article-title":"Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data","volume":"21","author":"Deodhar","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.cyto.2021.155715_b0070","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/rheumatology\/kex301","article-title":"Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study","volume":"56","author":"McInnes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.cyto.2021.155715_b0075","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","article-title":"Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions","volume":"43","author":"Patel","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2021.155715_b0080","doi-asserted-by":"crossref","unstructured":"W. Hueber, B.E. Sands, S. Lewitzky, M. Vandemeulebroecke, W. Reinisch, P.D. Higgins, J. Wehkamp, B.G. Feagan, M.D. Yao, M. Karczewski, J. Karczewski, N. Pezous, S. Bek, G. Bruin, B. Mellgard, C. Berger, M. Londei, A.P. Bertolino, G. Tougas, S.P. Travis, G. Secukinumab in Crohn's Disease Study, Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial, Gut 61(12) (2012) 1693-700.","DOI":"10.1136\/gutjnl-2011-301668"},{"issue":"11","key":"10.1016\/j.cyto.2021.155715_b0085","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/ajg.2016.298","article-title":"Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155715_b0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41598-019-57233-w","article-title":"Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2021.155715_b0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-dependent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2021.155715_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","article-title":"Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice","volume":"110","author":"Ogawa","year":"2004","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2015.06.024","article-title":"Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage","volume":"43","author":"Song","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1439","article-title":"The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease","volume":"8","author":"Qian","year":"2007","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2021.155715_b0115","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.4049\/jimmunol.1601540","article-title":"IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis","volume":"199","author":"Zepp","year":"2017","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155715_b0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.1736","article-title":"A protective function for interleukin 17A in T cell-mediated intestinal inflammation","volume":"10","author":"O'Connor","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2021.155715_b0125","doi-asserted-by":"crossref","unstructured":"J. Maxwell, Y. Zhang, W. Brown, C. Smith, F. Byrne, M. Florino, E. Stevens, J. Bigler, J. Davis, J. Rottman, A. Budelsky, A. Symons, J. Towne, Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation, Immunity 43 (2015) 739-50.","DOI":"10.1016\/j.immuni.2015.08.019"},{"issue":"9","key":"10.1016\/j.cyto.2021.155715_b0130","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.1200955","article-title":"Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis","volume":"189","author":"Cao","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/mi.2017.97","article-title":"Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation","volume":"11","author":"Li","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2021.155715_b0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41590-018-0134-y","article-title":"Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota","volume":"19","author":"Tang","year":"2018","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2021.155715_b0145","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"issue":"6025","key":"10.1016\/j.cyto.2021.155715_b0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4049\/jimmunol.1500909","article-title":"IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans","volume":"195","author":"Conti","year":"2015","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155715_b0160","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1189\/jlb.4A0915-428R","article-title":"Antibody blockade of IL-17-family cytokines in immunity to acute murine oral mucosal candidiasis","volume":"99","author":"Whibley","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2021.155715_b0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting Edge: IL-17-Secreting Innate Lymphoid Cells Are Essential for Host Defense against Fungal Infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2021.155715_b0170","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/ncomms2880","article-title":"Crystal structures of interleukin 17A and its complex with IL-17 receptor A","volume":"4","author":"Liu","year":"2013","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.cyto.2021.155715_b0175","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4049\/jimmunol.2000394","article-title":"An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F","volume":"205","author":"Zhou","year":"2020","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155715_b0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbrc.2008.09.019","article-title":"Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice","volume":"377","author":"Ito","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.cyto.2021.155715_b0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cyto.2021.155715_b0190","doi-asserted-by":"crossref","first-page":"a028522","DOI":"10.1101\/cshperspect.a028522","article-title":"Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications","volume":"10","author":"Monin","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"10.1016\/j.cyto.2021.155715_b0195","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543784.2013.806483","article-title":"IL-17 targeted therapies for psoriasis","volume":"22","author":"Chiricozzi","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"10.1016\/j.cyto.2021.155715_b0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"IL-23-IL-17 immune axis: From mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"10273","key":"10.1016\/j.cyto.2021.155715_b0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(21)00125-2","article-title":"Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial","volume":"397","author":"Reich","year":"2021","journal-title":"Lancet"},{"issue":"10273","key":"10.1016\/j.cyto.2021.155715_b0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(21)00126-4","article-title":"Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial","volume":"397","author":"Gordon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2021.155715_b0215","doi-asserted-by":"crossref","first-page":"32751","DOI":"10.1074\/jbc.M110.121418","article-title":"The SEFIR is not enough: An extended region downstream of the Interleukin-17RA SEFIR domain is required for IL-17-dependent signal transduction","volume":"285","author":"Onishi","year":"2010","journal-title":"J Biol Chem"},{"issue":"36","key":"10.1016\/j.cyto.2021.155715_b0220","doi-asserted-by":"crossref","first-page":"eaau9657","DOI":"10.1126\/sciimmunol.aau9657","article-title":"Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation","volume":"4","author":"Su","year":"2019","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155715_b0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20171849","article-title":"IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1(+) stem cells","volume":"216","author":"Chen","year":"2019","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.cyto.2021.155715_b0230","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical role of IL-17 receptor signaling in acute TNBS-induced colitis","volume":"12","author":"Zhang","year":"2006","journal-title":"Inflamm Bowel Dis"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621003045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621003045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:06:19Z","timestamp":1760907979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621003045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"alternative-id":["S1043466621003045"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155715","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155715"}}